The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS

Blood Adv. 2022 Aug 23;6(16):4705-4709. doi: 10.1182/bloodadvances.2022007858.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia* / genetics
  • Humans
  • Myelodysplastic Syndromes* / genetics
  • Phosphoproteins / metabolism
  • RNA Splicing Factors / genetics

Substances

  • Phosphoproteins
  • RNA Splicing Factors
  • SF3B1 protein, human